Eton Pharmaceuticals Inc’s recent filing unveils that its 10% Owner Opaleye Management Inc. acquired Company’s shares for reported $79814.0 on Oct 23 ’24. In the deal valued at $7.98 per share,10,000 shares were bought. As a result of this transaction, Opaleye Management Inc. now holds 2,770,000 shares worth roughly $40.66 million.
Then, Opaleye Management Inc. bought 33,970 shares, generating $238,782 in total proceeds. Upon buying the shares at $7.03, the 10% Owner now owns 2,760,000 shares.
Before that, Opaleye Management Inc. bought 16,852 shares. Eton Pharmaceuticals Inc shares valued at $114,105 were divested by the 10% Owner at a price of $6.77 per share. As a result of the transaction, Opaleye Management Inc. now holds 2,720,000 shares, worth roughly $39.93 million.
H.C. Wainwright reiterated its Eton Pharmaceuticals Inc [ETON] rating to a Buy in a research note published on January 23, 2025; the price target was $33. A number of analysts have revised their coverage, including B. Riley Securities’s analysts, who began to cover the stock in early January with a ‘”a Buy”‘ rating. H.C. Wainwright also remained covering ETON and reiterated its “Buy” recommendation on January 06, 2025.
Price Performance Review of ETON
On Tuesday, Eton Pharmaceuticals Inc [NASDAQ:ETON] saw its stock fall -3.99% to $14.68. Over the last five days, the stock has gained 4.11%. Eton Pharmaceuticals Inc shares have risen nearly 10.21% since the year began. Nevertheless, the stocks have risen 229.15% over the past one year. While a 52-week high of $18.41 was reached on 02/05/25, a 52-week low of $3.03 was recorded on 01/08/25. SMA at 50 days reached $15.34, while 200 days put it at $8.87.
Levels Of Support And Resistance For ETON Stock
The 24-hour chart illustrates a support level at 13.08, which if violated will result in even more drops to 11.47. On the upside, there is a resistance level at 15.94. A further resistance level may holdings at 17.19. The Relative Strength Index (RSI) on the 14-day chart is 47.04, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.31, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 44.77%. Stochastics %K at 68.52% indicates the stock is a holding.
How much short interest is there in Eton Pharmaceuticals Inc?
A steep rise in short interest was recorded in Eton Pharmaceuticals Inc stocks on 2025-02-28, dropping by 51514.0 shares to a total of 0.29 million shares. Yahoo Finance data shows the prior-month short interest on 2025-01-31 was 0.34 million shares. There was a decline of -17.8%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on May 06, 2024 when Craig Hallum began covering the stock and recommended ‘”a Buy”‘ rating along with a $8 price target.
